Market Overview:
The global oral solid dosage contract manufacturing market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for oral solid dosage forms from various application segments, such as specialty/midsize, generics, and big pharma companies. In addition, the growing demand for oral solid dosage forms in emerging markets is also contributing to the growth of this market. However, stringent regulatory norms and rising labor costs are some of the major factors restraining the growth of this market.
Product Definition:
Oral Solid Dosage Contract Manufacturing is the process of outsourcing the manufacturing of oral solid dosage forms, such as tablets and capsules, to a third party. This can be done for a variety of reasons, including to save money or increase production capacity. The importance of Oral Solid Dosage Contract Manufacturing lies in its ability to help manufacturers meet demand while keeping costs low.
Tablets:
Tablets are small solid dosage forms that are used to provide precise doses of medicine for oral consumption. They can be made from a variety of materials such as glass, plastic, and aluminum. Tablets have the advantage over other solid dosage forms in that they offer high stability and resistance towards degradation by acids found in the stomach which tend to cause effervescence or tingling sensation usually associated with non-prescription drugs.
Capsules:
Capsules are small hollow containers made from gelatin, glycerin, and paraffin that is used to deliver drugs. They are widely used in solid dosage formulations owing to their several advantages such as high stability and resistance against degradation. Capsules can be classified into two types: soft gelatin capsules containing liquid fillings and hard gelatin capsules consisting of dry fillings.
Application Insights:
Generics held the largest share of over 50.0% in 2017. The growing generic drug industry is a major factor driving the global oral solid dosage contract manufacturing market as it allows patients to access high-quality drugs at low costs. Generic manufacturers are also able to capitalize on their competitive edge by entering into partnerships with big pharma companies that offer advanced services such as clinical research, marketing and distribution channels for medicines under various brand names.
Specialty/midsize and specialty pharmacies dominated the other application segment with significant shares of 19.1%.
Regional Analysis:
Asia Pacific is anticipated to be the fastest-growing region over the forecast period. The growth of this region can be attributed to increasing R&D activities and rising healthcare expenditure in emerging economies, such as China and India. In addition, growing generic manufacturing industry due to increased competition among pharmaceutical companies is expected to drive the market for oral solid dosage contract manufacturing in Asia Pacific.
In addition, factors such as favorable government policies and availability of skilled workforce are expected to drive regional market growth during the forecast period.
Growth Factors:
- Increasing demand for oral solid dosage form drugs due to their advantages over other dosage forms
- Rising prevalence of chronic diseases, which leads to an increase in the demand for oral solid dosage form drugs
- Technological advancements in the field of oral solid dosage form drug manufacturing that improve product quality and efficiency
- Growing focus on outsourcing by pharmaceutical companies to reduce costs and improve efficiency
- Proliferation of contract manufacturers that offer high-quality services at competitive prices
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Solid Dosage Contract Manufacturing Market Research Report
By Type
Tablets, Capsules, Powders & Granules, Others
By Application
Specialty/Midsize, Generics, Big Pharma, Other
By Companies
Catalent, DPx, Lonza Group (Capsugel), Piramal Pharma Solutions, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie Contract Manufacturing, Nipro Pharma, Sopharma, Mylan (DPT Laboratories), Recipharm, NextPharma, Dishman, Aesica Pharmaceuticals, CordenPharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Oral Solid Dosage Contract Manufacturing Market Report Segments:
The global Oral Solid Dosage Contract Manufacturing market is segmented on the basis of:
Types
Tablets, Capsules, Powders & Granules, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Specialty/Midsize, Generics, Big Pharma, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Catalent
- DPx
- Lonza Group (Capsugel)
- Piramal Pharma Solutions
- Aenova
- Jubilant
- Famar
- Boehringer Ingelheim
- Fareva Holding
- AbbVie Contract Manufacturing
- Nipro Pharma
- Sopharma
- Mylan (DPT Laboratories)
- Recipharm
- NextPharma
- Dishman
- Aesica Pharmaceuticals
- CordenPharma
Highlights of The Oral Solid Dosage Contract Manufacturing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Capsules
- Powders & Granules
- Others
- By Application:
- Specialty/Midsize
- Generics
- Big Pharma
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Solid Dosage Contract Manufacturing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral solid dosage contract manufacturing is a process where pharmaceutical companies manufacture oral solid dosage forms, such as tablets and capsules. This process involves the production of a specific number of doses of a drug product, typically in large batches.
Some of the key players operating in the oral solid dosage contract manufacturing market are Catalent, DPx, Lonza Group (Capsugel), Piramal Pharma Solutions, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie Contract Manufacturing, Nipro Pharma, Sopharma, Mylan (DPT Laboratories), Recipharm, NextPharma, Dishman, Aesica Pharmaceuticals, CordenPharma.
The oral solid dosage contract manufacturing market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Solid Dosage Contract Manufacturing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Solid Dosage Contract Manufacturing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Solid Dosage Contract Manufacturing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Solid Dosage Contract Manufacturing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Solid Dosage Contract Manufacturing Market Size & Forecast, 2020-2028
4.5.1 Oral Solid Dosage Contract Manufacturing Market Size and Y-o-Y Growth
4.5.2 Oral Solid Dosage Contract Manufacturing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Capsules
5.2.3 Powders & Granules
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Specialty/Midsize
6.2.2 Generics
6.2.3 Big Pharma
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oral Solid Dosage Contract Manufacturing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oral Solid Dosage Contract Manufacturing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Capsules
9.6.3 Powders & Granules
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Specialty/Midsize
9.10.2 Generics
9.10.3 Big Pharma
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Capsules
10.6.3 Powders & Granules
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Specialty/Midsize
10.10.2 Generics
10.10.3 Big Pharma
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Capsules
11.6.3 Powders & Granules
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Specialty/Midsize
11.10.2 Generics
11.10.3 Big Pharma
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Capsules
12.6.3 Powders & Granules
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Specialty/Midsize
12.10.2 Generics
12.10.3 Big Pharma
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Capsules
13.6.3 Powders & Granules
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Specialty/Midsize
13.10.2 Generics
13.10.3 Big Pharma
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oral Solid Dosage Contract Manufacturing Market: Competitive Dashboard
14.2 Global Oral Solid Dosage Contract Manufacturing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Catalent
14.3.2 DPx
14.3.3 Lonza Group (Capsugel)
14.3.4 Piramal Pharma Solutions
14.3.5 Aenova
14.3.6 Jubilant
14.3.7 Famar
14.3.8 Boehringer Ingelheim
14.3.9 Fareva Holding
14.3.10 AbbVie Contract Manufacturing
14.3.11 Nipro Pharma
14.3.12 Sopharma
14.3.13 Mylan (DPT Laboratories)
14.3.14 Recipharm
14.3.15 NextPharma
14.3.16 Dishman
14.3.17 Aesica Pharmaceuticals
14.3.18 CordenPharma
